Myelofibrosis - 44 Studies Found
RECRUITING |
: Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm : Myelofibrosis : 2024-09-28 : ten (10) doses of Mutant-CALR peptides with KLH as helper peptide (in the first vaccine only).Mutant-CALR vaccine will administered every 2 week |
RECRUITING |
: Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) : Myelofibrosis (PMF) : 2024-09-28 : reparixin at 1200mg TID three times per day. |
RECRUITING |
: Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis : Myelofibrosis : 2024-09-28 : PegINFa will be given once every 2 weeks by subcutaneous administration in the abdomen or thigh. |
COMPLETED |
: Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis : Myelofibrosis : 2024-09-28 : Undergo follow-up assessment |